Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-J Kolb

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Vox Sanguinis|August 15, 1998
Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working PartiesH J Kolb
Klinische Padiatrie|January 1, 1977
[Bone marrow transplanation by aplastic anemia and acute leukemia--chances, success, indications (author's transl)]H J Kolb
HLA|April 4, 2017
Hematopoietic stem cell transplantation and cellular therapyH-J Kolb
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|July 1, 1980
Purification to homogeneity of an insulin-degrading enzyme from human erythrocytesH J Kolb, E Standl
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|December 1, 1987
[Clinical aspects of Menkes syndrome]H J Kolb, T Guthoff
European Journal of Clinical Investigation|March 31, 1976
The effect of fructose infusions on the oxygen transport system of human bloodE Standl, H J Kolb
Stem Cells (Dayton, Ohio)|January 1, 1997
Hematopoietic transplantation: state of the artH J Kolb, E Holler
European Journal of Biochemistry|August 15, 1979
Isolation of mitochondrial succinate: ubiquinone reductase, cytochrome c reductase and cytochrome c oxidase from Neurospora crassa using nonionic detergentH Weiss, H J Kolb
Current Opinion in Oncology|March 1, 1997
Adoptive immunotherapy with donor lymphocyte transfusionsH J Kolb, E Holler
Diabetologia|July 1, 1984
Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patientsE Standl, H J Kolb
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Vox Sanguinis|August 15, 1998
Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working PartiesH J Kolb
Klinische Padiatrie|January 1, 1977
[Bone marrow transplanation by aplastic anemia and acute leukemia--chances, success, indications (author's transl)]H J Kolb
HLA|April 4, 2017
Hematopoietic stem cell transplantation and cellular therapyH-J Kolb
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie|July 1, 1980
Purification to homogeneity of an insulin-degrading enzyme from human erythrocytesH J Kolb, E Standl
Monatsschrift Kinderheilkunde : Organ Der Deutschen Gesellschaft Fur Kinderheilkunde|December 1, 1987
[Clinical aspects of Menkes syndrome]H J Kolb, T Guthoff
European Journal of Clinical Investigation|March 31, 1976
The effect of fructose infusions on the oxygen transport system of human bloodE Standl, H J Kolb
Stem Cells (Dayton, Ohio)|January 1, 1997
Hematopoietic transplantation: state of the artH J Kolb, E Holler
European Journal of Biochemistry|August 15, 1979
Isolation of mitochondrial succinate: ubiquinone reductase, cytochrome c reductase and cytochrome c oxidase from Neurospora crassa using nonionic detergentH Weiss, H J Kolb
Current Opinion in Oncology|March 1, 1997
Adoptive immunotherapy with donor lymphocyte transfusionsH J Kolb, E Holler
Diabetologia|July 1, 1984
Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patientsE Standl, H J Kolb
Pageof 25